F
Fifth Eye
Health Tech & Medtech · Ann Arbor, United States · Founded 2017
Fifth Eye Enables Proactive Patient Care To Improve Outcomes, Avoid Adverse Events, Shorten Lengths Of Stay, And Reduce Costs MoreLess
Fifth Eye is a healthcare technology company specializing in real-time predictive analytics for hemodynamic instability, a condition where the blood flow is not stable. The company's core product is an advanced early warning system that helps medical professionals detect and respond to patient deterioration before it becomes critical. This technology is particularly valuable in intensive care units (ICUs) and emergency departments (EDs), where timely intervention can significantly improve patient outcomes and reduce mortality rates. Fifth Eye serves hospitals and healthcare providers, operating in the medical technology market. The business model is primarily subscription-based, where healthcare institutions pay for access to the predictive analytics platform. Revenue is generated through these subscriptions, as well as potential partnerships and licensing agreements. The company's technology leverages continuous monitoring and advanced algorithms to provide actionable insights, enabling proactive patient care. This not only helps in avoiding severe adverse events but also in shortening hospital stays and reducing overall healthcare costs. Keywords: predictive analytics, hemodynamic instability, early warning system, patient care, ICU, emergency department, healthcare technology, real-time monitoring, medical algorithms, cost reduction.
Company overview
Fifth Eye company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2017
- Headquarters
- Ann Arbor, United States
- Employees
- 5
- Open positions
- None listed
- Dealroom signal
- 58.3
Valuation & funding
Fifth Eye funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jun 2025 | $0 | — | Airstrip Technologies | ↗ |
| SERIES A✓Equity / VC | Apr 2019 | $12M | $46M | Arboretum Ventures · Cultivation Capital | — |
| SEED✓Equity / VC | Jul 2018 | $2.4M | $9.6M | InvestMichigan · Invest Michigan · Western Michigan University | — |
| SPINOUT✓Other financing | Apr 2017 | $0 | — | Stanford University | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 5 |
| 2025 | 7 |
| 2024 | 14 |
| 2023 | 22 |
| 2022 | 19 |
| 2021 | 14 |
| 2020 | 12 |
Growth signals
Fifth Eye website traffic
Latest recorded traffic for Fifth Eye is 720 monthly website visits, up 63.6% over the last three months. Fifth Eye's team declined 28.6% over the past year.
Comparisons
Fifth Eye compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Fifth Eye's talent
Source: Dealroom Talent Intelligence.
Investors
8 investors on Fifth Eye's cap table
Sourced from Dealroom's funding and investor records.








Global footprint
Where Fifth Eye has talent and traffic
team presence
In the news
Latest news about Fifth Eye
Recent press, funding announcements, and product moves mentioning Fifth Eye — open to read from the original sources.
Market sentiment
What the market is saying about Fifth Eye
An AI-synthesized read of the highest-engagement posts about Fifth Eye on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Fifth Eye’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






